Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
SurvivorNet on MSN
Diagnosing muscle-invasive bladder cancer: The initial work-up
When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...
Bladder cancer affects more than 86,000 people in the United States each year, according to the American Cancer Society, with the majority being over age 55. And while the disease can often be ...
EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ Endoscopy-America, Inc., a leader in endoscopy and related technology solutions, announced its system for performing Blue Light Cystoscopy with Cysview® ...
The goal of the course is to develop both resident skills and knowledge in the technique of cystoscopy to positively impact clinical practice, specifically basic cystoscopic knowledge and skills, ...
Add Yahoo as a preferred source to see more of our stories on Google. How does bladder cancer develop and what are the most common causes? In the last couple of years, Professor Syed Hussain has ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
—Sharon Waisbrod, MD, discusses a systematic review and meta-analysis of prospective and retrospective studies published over an 11-year period that evaluated the prevalence of cancer in patients with ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The KARL STORZ Photodynamic Diagnosis (PDD) System - Blue Light Cystoscopy with Cysview (BLCC) is one of the medical innovations that was showcased in front of ...
We used four deep learning models (ConvNeXt, PlexusNet, MobileNet, and SwinTransformer) covering a variety of model complexity and efficacy. We trained these models on a previously published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results